Every deal we've covered

Hawaii Pacific Health Partners bought All Access Ortho, Hawaii's leading orthopedic urgent care clinic with locations across O'ahu; WaveEdge advised the seller.

Chicago-based private equity firm Prairie Capital acquired California specialty blood products company Seraplex, adding it to a consortium of biospecimen businesses.

PharmaCorp Rx completed the C$1.3 million acquisition of a PharmaChoice-bannered pharmacy and a C$475,000 prescription file purchase, lifting its store count to 17.

Fresenius acquired the remaining 45% stake in Madrid-based mAbxience from Insud Pharma, giving Fresenius Kabi full ownership of the biosimilars platform it first took majority control of in 2022.

Resonant acquired Hamburg-based labfish rental solutions and its US and UK affiliates, adding clinical equipment rental, calibration and importer/exporter-of-record capabilities serving trial sites in over 70 countries.

SpyGlass Pharma acquired all outstanding shares of Advanced Vision Science, an ophthalmic device maker and intraocular lens manufacturer, from Santen Pharmaceutical for roughly $13 million in cash. AVS already supplies the IOL used in SpyGlass's two Phase 3 trials, and will remain Santen's exclusive IOL supplier in Japan while continuing to license lens material to Bausch + Lomb.

AstraZeneca is investing $2 billion in Summit Therapeutics via convertible preferred stock for about 12% ownership, alongside an alliance to test Summit's ivonescimab with AstraZeneca cancer drugs.

Terumo Neuro signed an agreement to acquire clinical-stage biomaterials company Arsenal Medical, adding the investigational NeoCast liquid embolic for chronic subdural hematoma; terms undisclosed.

Intune Physical Therapy acquired Clear Lake Physical Therapy & Rehab Specialists, a four-clinic western Wisconsin practice, lifting Intune to 22 clinics across five states.

NEXT10 plans to acquire an initial 49% stake and a board seat in BitFrontier Capital Holdings, then contribute health-and-wellness assets to lift ownership toward roughly 75-80%.

Integer Holdings said it received early termination of the Hart-Scott-Rodino waiting period for its pending acquisition by an affiliate of KKR-managed funds. The August 2 merger agreement values the medical device CDMO at $127 per share in cash, or roughly $5.7 billion in enterprise value. Shareholders vote at a special meeting on October 21, and the parties still expect to close by the end of 2026 pending other regulatory approvals.

Lifecore Biomedical agreed to be acquired by Webster Equity Partners in a transaction valued at up to $663.7 million, assuming full achievement of performance milestones. Shareholders receive $6.28 per share in cash at closing plus one non-tradable contingent right. Management framed the deal as funding the CDMO's next growth phase, with multiple customer programs potentially commercializing by the end of 2028.

Leica Biosystems, a Danaher company, completed its acquisition of StatLab Medical Products, a provider of pre-analytical pathology consumables, from Linden Capital Partners and Audax Private Equity.

TJP, backed by Renovus Capital Partners, acquired Evolution Consulting & Research, adding market research to its life sciences value and access agency platform.

ECGI Holdings entered a non-binding letter of intent to acquire Avanta Group for up to 15.6 million Series V preferred shares, with 80% of consideration vesting on recurring revenue milestones from $100 million to $400 million.

Zymeworks has completed its acquisition of Theravance Biopharma and issued final transaction details with updated 2026 guidance. The deal brings YUPELRI (revefenacin) into the portfolio, entitling Zymeworks to 35% of net U.S. profits plus ex-U.S. royalties via Theravance's Viatris collaboration. YUPELRI sales of $133.1 million in the first half of 2026 generated $38.4 million of collaboration revenue.

Boston-based RS2 Healthcare Partners completed a platform investment in KMM Group, a precision contract manufacturer for medical devices, and named J. Mark King CEO.

Aurora Cannabis filed an application with the Alberta Securities Commission seeking an order requiring Curaleaf to remedy alleged disclosure deficiencies in its hostile takeover bid circular.

Bio-Techne shareholders voted to approve the merger agreement under which Merck KGaA, Darmstadt, Germany would acquire the life science tools maker for cash.

Independent Pharmacy Cooperative acquired IntegralRx, a group purchasing organization serving thousands of independent pharmacies; terms were not disclosed.